Heres what we know about when generics might hit the market for the most in-demand GLP-1 drugs: Ozempic / Wegovy (semaglutide) Patents begin expiring in March 2026, but Novo Nordisk holds secondary patents that could extend exclusivity into 2033
At The Confidence Collective, were here to help you take control of your weight loss journey, without the confusion of fad diets and temporary fixes
The FDA's Category 2 designation means the substance may present significant safety risks when used in compounding and is prohibited in compounded medications pending further evaluation
Shes far more disparaging about creatine, though: Nobody [at BMC] uses creatine
During weight loss, even maintaining your strength levels can be a positive sign that youre preserving muscle
If you deprive people only of REM sleep, they start to overweigh the emotional significance of things